Brawn Biotech Ltd — Quarterly Results & Earnings

₹20.85

-0.71%

Profit Growth YoY120.59%Latest quarter

Sales Growth YoY48.18%Latest quarter

Sales CAGR 5Y-22.97%5 year compound

Profit CAGR 5YN/A5 year compound

📋

Quarterly Performance

YoY Profit Growth+120.59%

🔥 Exceptional growth

YoY Sales Growth+48.18%

🔥 Exceptional growth

OPM 5Y Average

Operating profit margin

-6.41%

EPS Growth 5Y

N/A

Interest Coverage

Higher = safer debt servicing

N/A

ROE

-41.33%

ROCE

-42.52%

💡

Growth Analysis

Brawn Biotech Ltd reported YoY profit growth of 120.59% and revenue growth of 48.18% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at -22.97% and profits at N/A annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Brawn Biotech Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.